Search
Results: 1
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.
Benjamin R Underwood, Zeyn W Green-Thompson, Peter J Pugh, Stanley E Lazic, Sarah L Mason, Jules Griffin, P Simon Jones, James B Rowe, David C Rubinsztein, Roger A Barker
May 31, 2018
Autophagy Cognition Interventional trial MRI Neurodegenerative disease Adolescent Adrenergic alpha-Agonists Adult Aged Brain Female Humans Huntington Disease Longitudinal Studies Magnetic Resonance Imaging Male Metabolomics Middle Aged Neuropsychological Tests Oxazoles Retrospective Studies Rilmenidine Time Factors Treatment Outcome Young Adult